Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new paper in Urologic Oncology, taken in combination with a media release and a video release from the UCLA Health System, have described a sophisticated method of combining data from magnetic resonance imaging (MRI) of the prostate with a three-dimensional (3D) ultrasound system to optimize outcomes of prostate biopsies.
Filed under: Diagnosis, Management, Risk | Tagged: Artemis, biopsy, magnetic resonance imaging, MRI, three-dimensional, tracking, transrectal, ultrasound | Leave a Comment »
A South Korean research team has just published data from a small, prospective, case-matched study comparing outcomes after cryotherapy + androgen deprivation therapy (CT + ADT) to outcomes after three-dimensional conformal radiation therapy + androgen deprivation (3D-CRT + ADT) in patients with high-risk prostate cancer.
Filed under: Management, Treatment | Tagged: "high risk", 3D-CRT, ADT, androgen deprivation therapy, conformation-beam, cryotherapy, outcome, radiation, three-dimensional | Leave a Comment »
A few days ago we reported on a study which concluded that the addition of high-dose-rate (HDR) brachytherapy to intensity-modulated radiation therapy (IMRT) had limited short-term clinical benefit in the treatment of localized prostate cancer compared to IMRT alone. Newly published Australian data is arguably supportive of this viewpoint.
Filed under: Management, Treatment | Tagged: 3D-CRT, brachytherapy, conformational radiation therapy, HDR, high-dose-rate, outcomes, three-dimensional | Leave a Comment »
In today’s other news reports there are items on: Mistrust between patients and their doctors regarding prostate cancer issues Use of a new, 3D transrectal ultrasound-guided biopsy system Pelvic lymph node dissection and its extent in prostate cancer staging and outcome Negative result of oblimersen sodium prior to docetaxel in castration-resistant prostate cancer
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, docetaxel, mistrust, oblimersen, pelvic lymph node dissection, PLND, three-dimensional, transrectal, ultrasound-guided | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site